US Recall News

United States Recall News Alerts for Recalled Drugs, Food, Products, & Vehicles

MENUMENU
  • Home
  • About
    • Advertise
  • Full Recall News Archive
    • Top Story

      J&J Settles Talc Mesothelioma Settlement

      By Sandra Dalton, Staff Writer On January 6, 2020, Superior Court Judge Stephen Kaus announced that Johnson & Johnsons (J&J) had agreed to … [Read More...]

      Daiso Issues Alergy Alert for Prepackaged Snacks

      Summary Company Announcement Date: February 03, 2023 FDA Publish Date: … [Read More...]

    • More Safety Articles
    • Federal Preemption of State Product Liability Law
  • Drug Recalls
    • Abilify
    • Benicar
    • Fluoroquinolones
    • Invokana
    • Lipitor
    • Nuplazid
    • Opioids
    • OxyContin
    • Pradaxa
    • Proton Pump Inhibitors (PPIs)
    • Risperdal
    • SSRI
    • Symptoms & Side Effects
    • Taxotere
    • Testosterone
    • Uloric
    • Valsartan
    • Xarelto
    • Zofran
  • Medical Devices
    • 3M Earplug
    • 3T Heater-Cooler System
    • Bair Hugger
    • Bipolar Hip System
    • Essure
    • Hip Replacements
    • Implanon
    • IVC Filters
    • Hernia Mesh
    • Power Morcellators
    • Shoulder Implants
    • Transvaginal Mesh
  • Food Recalls
    • FDA Press Releases
    • USDA Press Releases
  • Auto Recalls
    • Air Bags
    • Ignitions
    • NHTSA Press Releases
    • Off-Road Utility Vehicles
    • Snowmobiles
    • Tires
  • Other Products
    • Asbestos
    • Baby Products
    • Pet Products
    • Roundup
    • Talcum Powder
    • Toy Recalls
You are here: Home / Featured / The False Marketing of Risperdal

The False Marketing of Risperdal

October 8, 2015 By US Recall News Leave a Comment

Risperdal has been licensed by the FDA since February 1994 for use in psychotic episodes, with a particular emphasis on schizophrenia. It is made by Johnson & Johnson, who most of us know from their range of consumer products, such as baby powder and Listerine mouthwash. However, what is less well known is that Johnson & Johnson make most of the company’s profits (91% in 2014) from their medical devices and drug division with drugs such as Invokana (diabetes), Topamax (migraines), Xarelto (heart disease) and Risperdal (schizophrenia) contributing the vast bulk of Johnson & Johnson’s profits.

One of the key factors with drug profitability is the size of the patient population that the FDA will allow it to be prescribed to. For example, the American Diabetes Association estimated that there were 29.1 million diabetics in the United States in 2012, or approximately 9.3% of the population. Therefore, J&Js diabetic drug Invokana has that as a potential consumer base. By comparison, it is estimated that only around 1% of the U.S population suffer from schizophrenia, which is what Risperdal is primarily licensed for, so the potential population, while significant, should still be much smaller. Yet the financial data tells a different story.

In the first quarter of 2015, Invokana produced worldwide revenues of $278 million, while Risperdal had very similar results, with revenues of $254 million, despite appearing to be targeting a portion of the population with 9-times less people.

How come?

The answer increasingly seems to be that Johnson & Johnson have been marketing Risperdal to a wider audience then the FDA has licensed the drug for use on. There have now been numerous judgements against the company for deceptive marketing of Risperdal, including a $327 million judgement in South Carolina (reduced to $124 million on appeal), $158 million by the state of Texas, $7.5 million by the state of Arkansas and a $2.2 billion settlement with the U.S Justice Department to settle allegations of dubious marketing practices.

It is interesting to note that worldwide sales of Risperdal have dropped by 18.1% in the first quarter of 2015, and were previously much greater in revenue terms than Invokana, so recent heightened scrutiny on the way that this particular drug is being promoted may now be showing up in the bottom-line figures.

One of the big issues with Risperdal has been the age range of the patients that it is prescribed to. Since 1994, Johnson & Johnson have made repeated attempts with the FDA to widen the demographic to which the drug can be actively marketed to include geriatric patients, but the FDA, based on a lack of evidence of benefit, have rebuffed these. It is licensed for use in adults and adolescents, but with many more indications of side effects showing up in children, there should have been much more emphasis placed on the potential problems that may arise from its use.

This is particularly the case in children, with gynecomastia, which is the unwanted growth of breast tissue in men, showing up in one study in 30% of boys who used Risperdal.

There are now many cases pending in the U.S courts, which address this particular side effect and how patients were not informed of the potential problems with the drug. A recent Philadelphia judgement for $2.5 million to an autistic boy, Austin Pledger, who suffered from gynecomastia as a result of taking the drug, will almost certainly not be the last.

For more information on J&J as well as the marketing and legal tactics employed by the company, we encourage you to read the the in-depth article entitled America’s Most Admired Lawbreaker.

Share this:

  • Facebook
  • Twitter
  • LinkedIn
  • Email
  • Print

Related

Filed Under: Featured, Risperdal Tagged With: Risperdal

About US Recall News

US Recall News provides recall news and information to the United States general public. Find all of the latest drug, food, products, and vehicle recall news as reported by U.S. government agencies and more.

Leave a Reply Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Facebook
Thomas Roney LLC
Economic Consulting

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Daiso Issues Alergy Alert for Prepackaged Snacks

February 3, 2023 By The FDA

Fresh Ideation Food Group LLC Recalls Sandwiches and Other Products Because of Possible Health Risk

February 3, 2023 By The FDA

Global Pharma Healthcare Issues Voluntary Nationwide Recall of Artificial Tears Lubricant Eye Drops Due to Possible Contamination

February 2, 2023 By The FDA

Free Case Review

  • * = Required
    Privacy Policy
  • This field is for validation purposes and should be left unchanged.

Hero Highlight

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Children’s Robes Recalled Due to Violation of Federal Flammability Standards and Burn Hazard; Imported by BTPEIHTD; Sold Exclusively at Amazon.com

February 1, 2023 By The CPSC

Children’s Robes Recalled Due to Violation of Federal Flammability Standards and Burn Hazard; Imported by ChildLikeMe; Sold Exclusively at Amazon.com

February 1, 2023 By The CPSC

Children’s Robes Recalled Due to Violation of Federal Flammability Standards and Burn Hazard; Imported by SGMWVB Brand; Sold Exclusively on Amazon.com

February 1, 2023 By The CPSC

Shop Me Ca Recalls “Diep Bao Cream” Because of Possible Health Risk

February 1, 2023 By The FDA

B&G Foods Issues Voluntary Allergy Alert for Undeclared Peanut in Three Cases of Back to Nature® Fudge Mint Cookies

January 31, 2023 By The FDA

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Shop Me Ca Recalls “Diep Bao Cream” Because of Possible Health Risk

February 1, 2023 By The FDA

B&G Foods Issues Voluntary Allergy Alert for Undeclared Peanut in Three Cases of Back to Nature® Fudge Mint Cookies

January 31, 2023 By The FDA

IBSA Pharma Inc. Issues Voluntary Nationwide Recall of Select Lots of TIROSINT®-SOL (levothyroxine sodium) Oral Solution Due to Subpotency

January 30, 2023 By The FDA

Recall News in Your Inbox

Enter your email address to receive automated recall news updates.

Recent Comments

  • Roger McGowan on ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. Issues Nationwide Recall of All Lots of Dietary Supplement Products
  • Kathryn Moore on FDA Wants Cancer Warning on Breast Implants
  • BRAD on Huge ATV Recall by Polaris – Sportsman and Scrambler
  • Crystal Anderson on Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders
  • Outsourcing Training on The Modern Marketing of Pain
  • SANDRA Collett on Processed Food Preservative Linked to Autism?
  • Eric Karsh on Health Risks of Roundup Go Well Beyond Cancer

Recent Posts

  • Daiso Issues Alergy Alert for Prepackaged Snacks
  • Fresh Ideation Food Group LLC Recalls Sandwiches and Other Products Because of Possible Health Risk
  • Global Pharma Healthcare Issues Voluntary Nationwide Recall of Artificial Tears Lubricant Eye Drops Due to Possible Contamination
  • Paper Cape Recalls Children’s Pajamas Due to Violation of Federal Flammability Standards and Burn Hazard
  • Children’s Robes Recalled Due to Violation of Federal Flammability Standard and Burn Hazard; Imported by Betusline Official Apparel; Sold Exclusively on Amazon.com
  • Children’s Robes Recalled Due to Violation of Federal Flammability Standards and Burn Hazard; Imported by BTPEIHTD; Sold Exclusively at Amazon.com
  • Children’s Robes Recalled Due to Violation of Federal Flammability Standards and Burn Hazard; Imported by ChildLikeMe; Sold Exclusively at Amazon.com
  • Children’s Robes Recalled Due to Violation of Federal Flammability Standards and Burn Hazard; Imported by SGMWVB Brand; Sold Exclusively on Amazon.com
  • Shop Me Ca Recalls “Diep Bao Cream” Because of Possible Health Risk
-- See More Recall News

Disclaimer: The information contained in these topics is not intended nor implied to be a substitute for professional medical or legal advice, it is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.


ATTORNEY ADVERTISING. The information provided on this website is not legal advice. No attorney-client relationship is formed by the use of this site. It is not stated or implied that a lawyer is certified as a specialist in any particular field of law. No results are guaranteed, and prior results do not guarantee a similar outcome. This site is informational, only, not dispositive; it is up to you to decide whether a particular lawyer is right for you. Use of this site is subject to your agreement to these.


Copyright © 2023 Altrumedia · Terms of Service · Log in